Addex founder launches first Swiss spin-out from Merck Serono

François Conquet, the co-founder and former CEO of Addex Therapeutics, is to head a new company, Prexton Therapeutics, which is to be spun out of the soon-to-be-closed Geneva operations of Merck Serono.